This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hubbert, N L
Right arrow Articles by Schiller, J T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hubbert, N L
Right arrow Articles by Schiller, J T

 Previous Article  |  Next Article 

J Virol. 1992 October; 66(10): 6237-6241

Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes.

N L Hubbert, S A Sedman and J T Schiller

Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland 20892.

ABSTRACT

The E6 proteins of the high-risk human papillomaviruses (HPVs) have been shown to form a complex with and induce the degradation of human p53 in vitro. To determine whether p53 is degraded more rapidly in cells expressing E6 in vivo, the half-life of p53 was determined by pulse-chase analysis in early-passage normal human keratinocytes and fibroblasts, human keratinocytes immortalized with HPV type 16 (HPV16) E6 plus E7, and nonimmortal keratinocytes transfected with E6. The results of these experiments indicate that (i) the half-life of newly synthesized p53 is relatively long (4 h) in early-passage human keratinocytes and fibroblasts but short in keratinocytes expressing E6 (15 to 30 min), (ii) a similar increased rate of p53 degradation was measured in lines immortalized with HPV16 E6 plus E7 and senescent cells expressing E6, indicating that this increase is not simply the result of selection in the immortalized lines, and (iii) very low levels of expression of E6 result in a greatly decreased half-life of p53, suggesting that E6 acts in a catalytic manner.

J Virol. 1992 October; 66(10): 6237-6241




This article has been cited by other articles:

  • Harris, G. F. IV, Anderson, M. E., Lee, J. H. (2008). The Effect of Proteasome Inhibition on p53 Degradation and Proliferation in Tonsil Epithelial Cells. Arch Otolaryngol Head Neck Surg 134: 157-163 [Abstract] [Full Text]  
  • Ragin, C.C.R., Modugno, F., Gollin, S.M. (2007). The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus. JDR 86: 104-114 [Abstract] [Full Text]  
  • Parish, J. L., Kowalczyk, A., Chen, H.-T., Roeder, G. E., Sessions, R., Buckle, M., Gaston, K. (2006). E2 Proteins from High- and Low-Risk Human Papillomavirus Types Differ in Their Ability To Bind p53 and Induce Apoptotic Cell Death. J. Virol. 80: 4580-4590 [Abstract] [Full Text]  
  • Alam, S., Sen, E., Brashear, H., Meyers, C. (2006). Adeno-Associated Virus Type 2 Increases Proteosome-Dependent Degradation of p21WAF1 in a Human Papillomavirus Type 31b-Positive Cervical Carcinoma Line.. J. Virol. 80: 4927-4939 [Abstract] [Full Text]  
  • Nakashima, N, Kuwano, K, Maeyama, T, Hagimoto, N, Yoshimi, M, Hamada, N, Yamada, M, Nakanishi, Y (2005). The p53-Mdm2 association in epithelial cells in idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. J. Clin. Pathol. 58: 583-589 [Abstract] [Full Text]  
  • Longworth, M. S., Laimins, L. A. (2004). Pathogenesis of Human Papillomaviruses in Differentiating Epithelia. Microbiol. Mol. Biol. Rev. 68: 362-372 [Abstract] [Full Text]  
  • Nguyen, M., Song, S., Liem, A., Androphy, E., Liu, Y., Lambert, P. F. (2002). A Mutant of Human Papillomavirus Type 16 E6 Deficient in Binding {alpha}-Helix Partners Displays Reduced Oncogenic Potential In Vivo. J. Virol. 76: 13039-13048 [Abstract] [Full Text]  
  • Webster, K., Taylor, A., Gaston, K. (2001). Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins. J. Gen. Virol. 82: 201-213 [Abstract] [Full Text]  
  • Webster, K., Parish, J., Pandya, M., Stern, P. L., Clarke, A. R., Gaston, K. (2000). The Human Papillomavirus (HPV) 16 E2 Protein Induces Apoptosis in the Absence of Other HPV Proteins and via a p53-dependent Pathway. J. Biol. Chem. 275: 87-94 [Abstract] [Full Text]  
  • Liu, Y., Chen, J. J., Gao, Q., Dalal, S., Hong, Y., Mansur, C. P., Band, V., Androphy, E. J. (1999). Multiple Functions of Human Papillomavirus Type 16 E6 Contribute to the Immortalization of Mammary Epithelial Cells. J. Virol. 73: 7297-7307 [Abstract] [Full Text]  
  • Liu, Y., Tergaonkar, V., Krishna, S., Androphy, E. J. (1999). Human Papillomavirus Type 16 E6-enhanced Susceptibility of L929 Cells to Tumor Necrosis Factor alpha Correlates with Increased Accumulation of Reactive Oxygen Species. J. Biol. Chem. 274: 24819-24827 [Abstract] [Full Text]  
  • Talis, A. L., Huibregtse, J. M., Howley, P. M. (1998). The Role of E6AP in the Regulation of p53 Protein Levels in Human Papillomavirus (HPV)-positive and HPV-negative Cells. J. Biol. Chem. 273: 6439-6445 [Abstract] [Full Text]  
  • Alvarez-Salas, L. M., Cullinan, A. E., Siwkowski, A., Hampel, A., DiPaolo, J. A. (1998). Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes. Proc. Natl. Acad. Sci. USA 95: 1189-1194 [Abstract] [Full Text]  
  • Zabawski, E. J. Jr, Sands, B., Goetz, D., Naylor, M., Cockerell, C. J. (1997). Treatment of Verruca Vulgaris With Topical Cidofovir. JAMA 278: 1236-1236 [Abstract]  
  • Naka, T., Iwamoto, Y., Shinohara, N., Chuman, H., Tsuneyoshi, M. (1997). p53 Accumulation in Malignant Bone Tumors: An Immunohistochemical Analysis of 217 Cases. INT J SURG PATHOL 5: 1-9 [Abstract]  
  • Chen, J., Reid, C., Band, V, Androphy, E. (1995). Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269: 529-531 [Abstract]  
  • McNutt, N. S., Saenz-Santamaria, C., Volkenandt, M., Shea, C. R., Albino, A. P. (1994). Abnormalities of p53 Protein Expression in Cutaneous Disorders. Arch Dermatol 130: 225-232 [Abstract]  
  • Moles, J., Schiller, J., Tesniere, A, Leigh, I., Guilhou, J., Basset-Seguin, N (1994). Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression. J. Cell Sci. 107: 435-441 [Abstract]  
  • Nagano, T., Ueda, M., Ichihashi, M. (1993). Expression of p53 Protein Is an Early Event in Ultraviolet Light-Induced Cutaneous Squamous Cell Carcinogenesis. Arch Dermatol 129: 1157-1161 [Abstract]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»